THOMAS E SHENK
CIK 1204362 · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.63M
Companies
7
Total Filings
34
Lifetime Open-Market Net
-$200.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGTX | Director | 157,476 | $9.59 | $1.51M | -$200.0K | 10 | 2025-06-16 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 10,000 | — | — | $0 | 4 | 2018-05-24 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | — | $9.50 | — | $0 | 2 | 2017-06-30 |
| MRK | Director | 1,000 | $119.05 | $119.0K | $0 | 5 | 2011-05-31 |
| Merck & Co., Inc. (MRKpB) Delisted | Director | 1,000 | — | — | $0 | 3 | 2010-08-06 |
| CV THERAPEUTICS INC (CVTX) Delisted | Director | 8,500 | — | — | $0 | 4 | 2009-04-16 |
| CELL GENESYS INC (CEGE) Delisted | Director | 32,000 | — | — | $0 | 5 | 2008-07-01 |
Recent Filings · Page 3 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-11-04 | MRK | Disp (D) | −1,000 | $0 | EDGAR |
| 2009-10-16 | — | Disp (D) | −32,000 | $0 | |
| 2009-05-05 | MRK | Grant (A) | — | $0 | EDGAR |
| 2009-04-16 | CV THERAPEUTICS INC (CVTX) Delisted | Exer (M) | — | $0 | EDGAR |
| 2009-04-09 | CV THERAPEUTICS INC (CVTX) Delisted | Mixed | −47,927 | -$712.2K | EDGAR |
| 2008-07-01 | CELL GENESYS INC (CEGE) Delisted | Grant (A) | +4,000 | $0 | EDGAR |
| 2008-05-20 | CV THERAPEUTICS INC (CVTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-02 | MRK | Grant (A) | — | $0 | EDGAR |
| 2008-02-01 | CELL GENESYS INC (CEGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-11 | CELL GENESYS INC (CEGE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.